Quick Answer
Perspective Therapeutics, Inc. reported Net Income Loss of -$103.12 million for the year ending 2025.
- Perspective Therapeutics, Inc. showed a decrease of -30.1% in Net Income Loss from 2024 to 2025.
- This data is from Perspective Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: -$1.50 million | Q4 2016: -$1.45 million | Q1 2017: -$1.36 million | Q2 2017: -$1.85 million | Q3 2017: -$1.55 million | Q4 2017: -$1.46 million | Q1 2018: -$1.33 million | Q2 2018: -$2.34 million | Q3 2018: -$1.51 million | Q4 2018: -$1.41 million | Q1 2019: -$1.13 million | Q2 2019: -$1.10 million | Q3 2019: -$816.0 thousand | Q4 2019: -$897.0 thousand | Q1 2020: -$545.0 thousand | Q2 2020: -$1.19 million | Q3 2020: -$713.0 thousand | Q4 2020: -$868.0 thousand | Q1 2021: -$745.0 thousand | Q2 2021: -$1.06 million | Q3 2021: -$2.24 million | Q4 2021: -$1.60 million | Q1 2022: -$1.35 million | Q2 2022: -$2.08 million | Q3 2022: -$4.07 million | Q1 2023: -$371.0 thousand | Q2 2023: -$11.11 million | Q3 2023: -$10.36 million | Q1 2024: -$12.28 million | Q2 2024: -$11.70 million | Q3 2024: -$15.12 million | Q1 2025: -$18.18 million | Q2 2025: -$21.49 million | Q3 2025: -$25.97 million.
- Over the full 15 years of available data (2012 to 2025), Perspective Therapeutics, Inc.'s Net Income Loss has declined by 2,855.7%.
- Historical annual values: Fiscal year 2025: -$103.12 million | Fiscal year 2024: -$79.28 million | Fiscal year 2023: -$46.51 million | Fiscal year 2022: -$10.76 million | Fiscal year 2022: -$7.27 million | Fiscal year 2021: -$3.39 million | Fiscal year 2020: -$3.45 million | Fiscal year 2019: -$5.14 million | Fiscal year 2018: -$6.70 million | Fiscal year 2017: -$6.16 million | Fiscal year 2016: -$4.71 million | Fiscal year 2015: -$3.68 million | Fiscal year 2014: -$5.96 million | Fiscal year 2013: -$3.86 million | Fiscal year 2012: -$3.49 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: